Brady Stephen R 4
4 · Tempest Therapeutics, Inc. · Filed Jul 8, 2024
Insider Transaction Report
Form 4
Brady Stephen R
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2024-07-03$2.11/sh+35,000$73,850→ 46,376 total
Footnotes (1)
- [F1]Includes 11,376 shares acquired under the Issuer's stock purchase plan.